C4 Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
The company stated in the following report that they exploit animals for product testing.
“The increase of $19.5 million was primarily due to an increase of $14.0 million in preclinical studies and external CRO costs attributable to an increase in the volume of animal models and drug metabolism and PK studies for our product candidates and an increase of $4.4 million in compensation and related personnel costs attributable to an increase in headcount.” (Page 78) Read the full document
C4 Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on harnessing the body’s natural regulation of protein levels to develop therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
Company Website: https://c4therapeutics.com